Showing 421 - 440 results of 100,179 for search '(( 5 non decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 421
  2. 422
  3. 423

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  4. 424
  5. 425
  6. 426

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

    Published 2016
    “…Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. …”
  7. 427
  8. 428

    Frictional Effects on RNA Folding: Speed Limit and Kramers Turnover by Naoto Hori (767562)

    Published 2018
    “…In the high-friction regime (η ≳ 10<sup>–5</sup> Pa·s), for both HP and PK, <i>k</i><sub>F</sub> values decrease as 1/η, whereas in the low friction regime, <i>k</i><sub>F</sub> values increase as η increases, leading to a maximum folding rate at a moderate viscosity (∼10<sup>–6</sup> Pa·s), which is the Kramers turnover. …”
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437
  18. 438

    Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial by Seyyed Abbas Zojaji (5208589)

    Published 2022
    “…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”
  19. 439
  20. 440

    TRIM5 restriction of HIV-1 has decreased during evolution leading to humans. by Michael Emerman (12304)

    Published 2013
    “…Original data is found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1000301#pbio.1000301-Goldschmidt1" target="_blank">[30]</a> and shows that the antiviral gene TRIM5 restricted HIV-1 better at points in evolution earlier than the chimp–human common ancestor than it does after that. …”